Your browser doesn't support javascript.
loading
Expression of BCL2 alternative proteins and association with outcome in CLL patients treated with venetoclax.
Marques-Piubelli, Mario L; Schlette, Ellen J; Khoury, Joseph D; Furqan, Fateeha; Vega, Francisco; Soto, Luisa M Solis; Wistuba, Ignacio I; Wierda, William G; Konopleva, Marina; Ferrajoli, Alessandra; Strati, Paolo.
Afiliação
  • Marques-Piubelli ML; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Schlette EJ; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Furqan F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vega F; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Soto LMS; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ferrajoli A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Strati P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leuk Lymphoma ; 62(5): 1129-1135, 2021 05.
Article em En | MEDLINE | ID: mdl-33327833

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Antineoplásicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos